Validation of Analytical method.ppt

Method Validation

1. Presented by
Priyanka Yadav
1

2. Definition:
•Methodvalidationistheprocessofproving
thatananalyticalmethodisacceptableforits
intendedpurposes.
•Validationofanalyticalproceduresisthe
processofdeterminingthesuitabilityofa
givenmethodologyforprovidinguseful
analytical data.
METHOD VALIDATION = ERROR ASSESSMENT
2

3. 1.Developsconfidenceinusingthemethod&
Proofthatmethodissuitableforitsintended
purpose, The purpose ofanalytical
measurementistogetconsistent,reliableand
accuratedata.
2.Regulatoryrequirement,Equalimportancefor
thoseworkinginaregulatedandinan
accreditedenvironment.
◦U.S.FDA,ISOetc.
3

4. Whentobevalidated?
•Partialvalidation
•Completevalidation
Whichmethodsaretobevalidated
•Compendial:Pharmacopoeialmethod
•Verificationofsuitabilityofmethod
•Noncompendialmethods:Laboratory
developedmethods.
outsideitsscope.
4

5. 5
Validation
Development Optimization

6. Category 1: Quantitation of major components or
active ingredients
Category 2: Determination of impurities or
degradation products
Category 3: Determination of performance
characteristics
6

7. 7
Type of
Analytical
Procedure
Identification
Impurity testing
Assay
QuantitativeLimit Tests
Accuracy No Yes No Yes
Precision
Repeatability No Yes No Yes
Interm. Prec. No Yes No Yes
Specificity Yes Yes Yes Yes
LOD No No Yes No
LOQ No Yes No No
Linearity No Yes No Yes
Range No Yes No Yes

8. Ability of an analytical method to measure the analytefree
from interference due to other components.
Selectivity describes the ability of an analytical method to
differentiate various substances in a sample
Degree of Bias (Used in USP)
The difference in assay results between the two groups
-the sample containing added impurities, degradation products, related
chemical compounds, placebo ingredients
-the sample without added substances
8

9. Chromatographic Methods
◦Demonstrate Resolution
Impurities/DegradantsAvailable
◦Spike with impurities/degradants
◦Show resolution and a lack of interference
Impurities/DegradantsNot Available
◦Stress Samples
◦For assay, Stressed and Unstressed Samples should be
compared.
◦For impurity test, impurity profiles should be compared.
9

10. Ability of an assay to
elicit a direct and
proportional
response to changes
in analyte
concentration.
10

11. By Visual Inspection of plot of signals vs. analyte
concentration
By Appropriate statistical methods
◦Linear Regression (y = mx+ b)
◦Correlation Coefficient
Acceptance criteria: Linear regression r
2
> 0.95
Requires a minimum of 5 concentration levels
11

12. Acceptable range having linearity, accuracy, precision.
For Drug Substance & Drug product Assay
◦80 to 120% of test Concentration
For Content Uniformity Assay
◦70 to 130% of test Concentration
For Dissolution Test Method
◦+/-20% over entire Specification Range
For Impurity Assays
◦From Reporting Level to 120%of Impurity Specification for
Impurity Assays
◦From Reporting Level to 120%of Assay Specification for
Impurity/Assay Methods
12

13. Closeness of the test
results obtained by the
method to the true value.
13

14. Should be established across specified range of
analytical procedure.
Should be assessed using a minimum of 3
concentration levels, each in triplicate (total of 9
determinations)
Should be reported as:
◦Percent recovery of known amount added or
◦The difference between the mean assay result and the
accepted value
14

15. The closeness of agreement
(degree of scatter) between a
series of measurements obtained
from multiple samplings of the
same homogeneous sample.
Should be investigated using
homogeneous, authentic samples.
15

16. Repeatability
Intermediate Precision
Reproducibility
16

17. Express the precision under the same operating
conditions over a short interval of time.
Also referred to as Intra-assay precision
17
Should be assessed using minimum of 9
determinations
(3 concentrations/ 3 replicates) or
Minimum of 6 determinations at the 100% level.

18. 18
Express within-laboratory variations.
Expressed in terms of standard deviation, relative
standard deviation (coefficient of variation) and
confidence interval.
Depends on the circumstances under which the procedure is
intended to be used.
Studies should include varying days, analysts, equipment, etc.

19. Day 1 Day 2
100.6 99.5
100.8 99.9
100.1 98.9
100.3 99.2
100.5 99.7
100.4 99.6
19
Grand
Mean = 100.0
RSD = 0.59%
Mean = 100.5
RSD = 0.24%
Mean = 99.5
RSD = 0.36%

20. Definition: Ability reproduce data within the predefined
precision
Determination: SD, RSD and confidence interval
◦Repeatability test at two different labs.
Note: Data not required for BLA/NDA
20

21. LOD
Lowest amount of analyte
in a sample that can be
detected but not
necessarily quantitated.
Estimated by Signal to
Noise Ratio of 3:1.
21
LOQ
Lowest amount of analyte
in a sample that can be
quantified with suitable
accuracy and precision.
Estimated by Signal to
Noise Ratio of 10:1.

22. 1.Based in Visual Evaluations
-Used for non-instrumental methods
2.Based on Signal-to Noise-Ratio
-3:1 for Detection Limit
-10:1 for Quantitation Limit
3.Based on Standard Deviation of the Response
and the Slope
22
LOD and LOQ Estimated by

23. S = slope of calibration curve
s = standard deviation of blank readings or
standard deviation of regression line
Validated by assaying samples at DL or QL
23
DL =
3.3s
QL =
10s
S S
LOD and LOQ Estimated by

24. Definition: Capacity to remain unaffected by small but
deliberate variations in method parameters
Determination: Comparison results under differing conditions
with precision under normal conditions
Examples of typical variations in LC
◦Influence of variations of pH in a mobile phase
◦Influence of variations in mobile phase composition
◦Different columns (different lots and/or suppliers)
◦Temperature
◦Flow rate
24
Robustness

25. Degree of reproducibility of test results under a
variety of conditions
Different Laboratories
Different Analysts
Different Instruments
Different Reagents
Different Day etc.
Expressed as %RSD
25

26. When
◦Method parameters have been changed
◦The scope of the method has been changed
◦Synthetic methods have been changed
◦Impurity profile has been changed
What
◦Preferably everything. Exceptions should be
scientifically justified
26

27. 27

28. Laboratory Instrument Qualification:
◦Design Qualification (DQ): traditionally vendor
driven
◦Installation Qualification (IQ): user/vendor driven
◦Operational Qualification (OQ): user/vendor driven
◦Performance Qualification (PQ): user driven
User is responsible for documenting all levels of
qualification
28

29. Purpose:To Document continuing suitability of HPLC system
for all anticipated applications and to assure it is
kept under optimum maintenance and calibration
conditions
Qualification Documentation and Protocols
◦User is responsible for documenting all levels of qualification
◦Documentation can be prepared by user and/or vendor
◦GMP vs non-GMP Equipment (contract laboratories)
DQ IQ OQ PQ
29

30. Instrument Specifications and Selection Criteria
◦Modular or integrated system, software control, data
acquisition, processing and presentation
◦Sample preparation and introduction (sample injection,
autosamplers, injection volume, needle wash, etc.)
◦Construction materials
◦Documentation (manuals, CDs, SOPs)
◦Maintenance and support (ease of use, cost and availability
of parts, service and technical support
◦Training requirements and training materials
◦Equipment environment and safety conditions
30

31. Instrument received as specified and properly
installed
Utilities
Environment
Establish Calibration Schedule
Establish Preventative Maintenance Protocol
Identify SOPs
Identify Training
31

32. Verification of key performance aspects (modular, not
method related)
◦To assure that main operating parameters (injection
volume, flow rate, mobile phase mixing, column
temperature control, detection wavelength) are within
specified limits
◦Conducted after initial installation, system maintenance
and repair, and repeated periodically
◦Conducted in-house
◦Frequency will depend on manufacturer’s
recommendations, required performance, degree of use,
nature of use and instrument history
32

33. Demonstration of suitability of “entire” HPLC system for
routine use
◦Vendor normally will conduct holistic performance test
following initial OQ to verify entire system performance by
analyzing a test mixture using a test column under defined
conditions
◦User must conduct further tests, on regular basis, to
provide continued evidence of system suitability and
satisfactory instrument performance
◦PQ tests need to be simple, noninvasive, and
comprehensive
◦PQ tests can be built into system suitability tests (SST) to
assure evidence of satisfactory precision and linearity over
desired range
33

34. Critical HPLC PQ Parameters:
Injection volume precision (< 1% RSD)
Injection volume linearity (in some cases)
Injection carryover (using a blank; method specific)
Flow rate precision (< 0.5% RSD RT)
Column oven temperature (< 0.5% RSD RT)
Linearity of detector response (using standards; method
specific)
Signal to noise ratio (using dilute standards and blank;
method specific)
34

35. CALIBRATION OF INSTRUMENT :
◦injector performance.
◦pump performance
◦detector performance
◦column oven temperature
◦computer data acquisition system performance
35

36. PUMP PERFORMANCE :
Gradient Accuracy and Precision
Pressure Test.
Flow Rate Accuracy
Pump performance can be check by flow
rate of mobile phase, by simply collecting
the mobile phase at the detector outlet over
a specific time period or using a
commercially available flow meter.
Acceptance criteria: the flow rate shall be
within ±1.0 ℅ of the set value/ min.
36

37. INJECTOR PERFORMANCE :
The overall system precision can be done by
injecting a standard and calculating the
percentage relative standard deviation.
(%RSD)
As std. benzophenone or naphthalene is
used.
Precision
Carryover
Linearity.
Acceptance criteria: %RSD shall be less than
1.0%.
37

38. DETECTOR PERFORMANCE :
Wavelength Accuracy
Noise and Drift.
Linearity of Response
Three std. solution of benzophenone is used to check
detector linearity
Prepared std. solution of 0.025 mg/ml , 0.05mg/ml,
0.075mg/ml, 0.100mg/ml,0.150mg/ml in methanol.
Duplicate of each stds are run on the system.
After collecting data from the system, plot a graph of
peak area(Y) versus concentration(X) in mg/ml and
calculate the correlation coefficient.
Acceptance criteria: the correlation coefficient value
shall be not less than 0.98.
38

39. COLUMN OVEN TEMPERATURE :
◦Determine the column oven temperature, using
standard mercury thermometer. Measure it six
time at different time interval.
◦Acceptance criteria : the ℅ RSD shall be less than
1.0 ℅
39

40. AUTO VALIDATION:
◦Detector wavelength accuracy
◦Lamp energy
◦Flow rate stability
◦Temperature adjustment precision
◦Absorbance accuracy
◦Detector baseline drift
◦Detector baseline noise
◦Pressure limiter
◦Gradient concentration accuracy
40

41. 1.Chung Chow Chan Eli Lilly,” Analytical
Method Validation and Instrument
Performance Verification”, A john Wiley and
sons, inc. (2004) 173
2.ICH guidelines Q2(R1)
3.Jens t. cartensen and C.T. Rhodes, ”drug
stability –principles and practice”3
rd
edision,353-369
41

42. 42